Picture of Glow Lifetech logo

GLOW — Glow Lifetech News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

ASX shares of MGC Pharma rise on application for Artemi to Health Canada

** Shares of MGC Pharmaceuticals  MXC.AX  jump as much as
5.3% to A$0.060, snapping its three-day losing streak
    ** European-based biopharma co says its Canadian-based
development and distribution partner Glow LifeTech  GLOW.CD 
submitted an application to Health Canada, a government
department responsible for national health policy  urn:newsml:reuters.com:*:nASX7yKcq9
    ** Says application is to obtain product licenses for 
Artemic as a Natural Health Product  urn:newsml:reuters.com:*:nGLF6BmL9c
    ** Artemic is a clinically tested oral spray which
statistically improved recovery of COVID-19 patients 
    ** "The global demand for natural health products has been
driven to new highs during pandemic and Health Canada approved
products are globally recognized as safe and high-quality," said
Rob Carducci, Chief Commercial Officer, Glow LifeTech
    ** Stock has risen over two-fold this year, as of last close
    
  

 (Reporting by Vasudha Kaukuntla in Bengaluru)
 ((Vasudha.Kaukuntla@thomsonreuters.com))

Recent news on Glow Lifetech

See all news